Recent Advances in Therapy of Sepsis: Focus on Recombinant Bactericidal/Permeability-Increasing Protein (BPI)

ISSN： 1173-8804

Source： BioDrugs, Vol.9, Iss.6, 1998-06, pp. : 435-442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Anti-Tumour Necrosis Factor (TNF) Therapy in Rheumatoid Arthritis: Focus on the Soluble TNF Receptor p75 Fusion Protein, Etanercept

By Moreland L.W.

BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 201-210

Adis International

Access to resources Recommend Favorite

Relationship Between the Inflammation and Coagulation Pathways in Patients with Severe Sepsis: Implications for Therapy with Activated Protein C

By Morris P.E. Hite R.D. Ohl C.

BioDrugs, Vol. 16, Iss. 6, 2002-01 ,pp. : 403-417

Adis International

Access to resources Recommend Favorite

Recombinant Hirudins: An Overview of Recent Developments

By Zeymer U.

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 425-436

Adis International

Access to resources Recommend Favorite

Recent advances in the treatment of ARDS

By ROSSAINT R PAPPERT D FRITZ G

Clinical Intensive Care, Vol. 6, Iss. 2, 1995-04 ,pp. : 62-62

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Antisense Oligonucleotides in Cancer: Recent Advances

By Lebedeva I.V. Stein C.A.

BioDrugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 195-216

Adis International

Access to resources Recommend Favorite